TY  - JOUR 
AU  - Antolin, A. Rodriguez
AU  - Martinez-Pineiro, L.
AU  - Romero, M. E. Jimenez
AU  - Ramos, J. B. Garcia
AU  - López Bellido, Dionisio
AU  - del Toro, J. Munoz
AU  - Garcia-Porrero, A. Garcia
AU  - Veiga, F. Gomez
PY  - 2019
SN  - 1471-2490
UR  - http://hdl.handle.net/20.500.11940/16065
AB  - BACKGROUND: Fatigue is one of the most prevalent symptoms among cancer patients. Specifically, in metastatic castration-resistant prostate cancer (mCRPC) patients, fatigue is the most common adverse event associated with current treatments. The...
LA  - eng
KW  - Middle Aged
KW  - Humans
KW  - Cross-Sectional Studies
KW  - Prostatic Neoplasms
KW  - Fatigue
KW  - Quality of Life
KW  - Aged
KW  - Prevalence
TI  - Prevalence of fatigue and impact on quality of life in castration-resistant prostate cancer patients: the VITAL study
DO  - 10.1186/s12894-019-0527-8
T2  - Bmc urology
M2  - 92
KW  - CHUO
VL  - 19
ER  -